Yoder Stephen S. 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Yoder Stephen S.
DirectorCEO and President
Transactions
- Award
Stock Option (Right to buy)
2023-02-24+634,021→ 634,021 totalExercise: $1.39Exp: 2033-02-24→ Common Stock (634,021 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on February 24, 2024 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.